Review article · 2025 · Open access

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, Yu Huang, Junyi Mao, Zheng Wei, Yonghe Hu, Jianyou Shi

Signal Transduction and Targeted Therapy, 10(1), 74 · Published 4 March 2025 · DOI 10.1038/s41392-024-02107-5

Read the free full textCite this paper

In brief

“Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines” is a 2025 review article by Wen‐Jing Xiao and 7 co-authors, published in Signal Transduction and Targeted Therapy. OpenAlex counts 505 citations as of 15 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Signal Transduction and Targeted Therapy.

Citations
505
Most cited in
2026 (366)
Field-weighted impact
37.72
References
829
Authors
8

Abstract

The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines. The integration of novel drug design and synthesis techniques, display library technology, delivery systems, bioengineering advancements, and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs, effectively addressing the obstacles associated with their character, such as the rapid clearance and degradation, necessitating subcutaneous injection leading to increasing patient discomfort, and ultimately advancing translational research efforts. Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions, such as diabetes mellitus, weight loss, oncology, and rare diseases, and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines. This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics, delivery platforms, and vaccines. It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs, as well as the recent advancements in screening, design, and delivery technologies. The accelerated advancement in the development of novel peptide-based therapeutics, including peptide-drug complexes, new peptide-based vaccines, and innovative peptide-based diagnostic reagents, has the potential to promote the era of precise customization of disease therapeutic schedule.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Wei, Z., Hu, Y., & Shi, J. (2025). Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduction and Targeted Therapy, 10(1), 74. https://doi.org/10.1038/s41392-024-02107-5

MLA 9

Xiao, Wen‐Jing, et al. “Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.” Signal Transduction and Targeted Therapy, vol. 10, no. 1, 2025, p. 74. https://doi.org/10.1038/s41392-024-02107-5.

Chicago

Xiao, Wen‐Jing, Wenjie Jiang, Zheng Chen, Yu Huang, Junyi Mao, Zheng Wei, Yonghe Hu, and Jianyou Shi. 2025. “Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.” Signal Transduction and Targeted Therapy 10 (1): 74. https://doi.org/10.1038/s41392-024-02107-5.

Harvard

Xiao, W. et al. (2025) ‘Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines’, Signal Transduction and Targeted Therapy, 10(1), p. 74. doi:10.1038/s41392-024-02107-5.

IEEE

W. Xiao et al., “Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines,” Signal Transduction and Targeted Therapy, vol. 10, no. 1, p. 74, 2025, doi: 10.1038/s41392-024-02107-5.

BibTeX

@article{xiao2025advance,
  title     = {{Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines}},
  author    = {Xiao, Wen‐Jing and Jiang, Wenjie and Chen, Zheng and Huang, Yu and Mao, Junyi and Wei, Zheng and Hu, Yonghe and Shi, Jianyou},
  journal   = {Signal Transduction and Targeted Therapy},
  year      = {2025},
  volume    = {10},
  number    = {1},
  pages     = {74},
  doi       = {10.1038/s41392-024-02107-5},
  url       = {https://doi.org/10.1038/s41392-024-02107-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis

  • peptide therapeutics
  • peptide vaccine
  • peptide delivery systems
  • artificial intelligence in drug design
  • peptide degradation
  • subcutaneous injection
  • diabetes mellitus
  • weight loss

Work with this paper

Most-cited papers in Chemistry

All highly cited Chemistry papers

Questions about this paper

How do I cite this paper in APA style?

Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Wei, Z., Hu, Y., & Shi, J. (2025). Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduction and Targeted Therapy, 10(1), 74. https://doi.org/10.1038/s41392-024-02107-5

How many times has this paper been cited?

505 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Signal Transduction and Targeted Therapy.

Who wrote this paper?

Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, Yu Huang, Junyi Mao, Zheng Wei, Yonghe Hu, Jianyou Shi.

What is the DOI of this paper?

10.1038/s41392-024-02107-5. The permanent link is https://doi.org/10.1038/s41392-024-02107-5.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.